文献速递细菌感染、耐药与抗菌药物医院感染防控

既往抗生素使用与急症入院多重耐药菌定植的关联:全国病例对照研究

Colonization with multiresistant bacteria in acute hospital care: the association of prior antibiotic consumption as a risk factor.
PubMed 文献 · J Antimicrob Chemother · 2020-01-01

该全国病例对照研究纳入256例多重耐药菌定植患者与4763例对照,发现入组前2年内77%病例和68%对照至少有一次抗生素处方(P=0.002)。青霉素类(OR=1.58-1.65)和氟喹诺酮类(OR=2.25-6.15)处方与ESBL-E定植风险显著增加相关,且风险在暴露后可持续至2年。

要点

  • 既往2年抗生素处方与ESBL-E定植风险增加相关。
  • 氟喹诺酮类与ESBL-E定植的关联强度高于青霉素类。
  • 青霉素类、氟喹诺酮类和大环内酯类暴露后2年内定植风险仍显著升高。

核心结论

  • ESBL-E定植患病率与氟喹诺酮类、大环内酯类和青霉素类使用相关,且抗生素治疗后风险至少持续2年。

研究设计与样本

  • 全国性病例对照研究,纳入急诊就诊成人,采集咽、鼻、直肠拭子检测ESBL-E、MRSA、产碳青霉烯酶肠杆菌和VRE定植。
  • 通过国家登记系统收集入组前2年个体水平抗生素史,进行多因素分析及ESBL-E定植亚组分析。
  • 共纳入256例多重耐药菌定植病例和4763例对照。

主要发现

  • 入组前2年内,77%病例和68%对照至少有一次抗生素处方(P=0.002)。
  • 青霉素类处方与ESBL-E定植风险显著增加相关(OR=1.58-1.65)。
  • 氟喹诺酮类处方与ESBL-E定植风险显著增加相关(OR=2.25-6.15)。
  • 全部多重耐药菌定植患者分析显示类似结果。
  • 时间线评估显示青霉素类、氟喹诺酮类和大环内酯类暴露后2年内定植风险显著增加。

临床怎么用

  • 急诊评估多重耐药菌定植风险时,应关注患者近2年抗生素使用史,尤其是氟喹诺酮类、青霉素类和大环内酯类。
  • 对有上述抗生素暴露史的患者,可考虑加强多重耐药菌筛查与感染防控措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antibiotic resistance poses a worldwide threat and knowledge concerning risk factors for colonization with multiresistant bacteria (MRB) is limited. OBJECTIVES: To examine the impact of prior antibiotic consumption on MRB colonization, with focus on type of antibiotic and timeline between antibiotic prescription and MRB colonization. METHODS: A nationwide case-control study was conducted and adults visiting emergency departments were invited to participate. All patients were swabbed in the throat, nose and rectum, and analysed for colonization with ESBL-producing Enterobacteriaceae (ESBL-E), MRSA, carbapenemase-producing enterobacteria and VRE. Antibiotic history 2 years prior to enrolment was collected at an individual level through a national register. Multivariate analyses were performed to examine the association between antibiotic consumption and MRB status. A subgroup analysis of ESBL-E-colonized cases was made. RESULTS: We included 256 patients colonized with MRB and 4763 controls. In the 2 years prior to study inclusion, 77% of cases and 68% of controls had at least one antibiotic prescription (P = 0.002). We found a significant increase in risk of colonization with ESBL-E if penicillins (OR = 1.58-1.65) or fluoroquinolones (OR = 2.25-6.15) were prescribed. The analysis of all MRB-colonized patients showed similar results. An assessment of the timeline showed a significant increase in risk of colonization up to 2 years after exposure to penicillins, fluoroquinolones and macrolides. CONCLUSIONS: The prevalence of ESBL-E colonization was related to fluoroquinolone, macrolide and penicillin consumption for at least 2 years after antibiotic treatment.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Dualleh N, Chanchiri I, Skjøt-Arkil H, et al. Colonization with multiresistant bacteria in acute hospital care: the association of prior antibiotic consumption as a risk factor. J Antimicrob Chemother. 2020. PMID: 32814968. doi:10.1093/jac/dkaa365

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。